These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12402066)

  • 1. Serum soluble interleukin-2 receptor (IL-2R) and immunohistochemical staining of IL-2R/Tac antigen in colorectal cancer.
    Sakata H; Murakami S; Hirayama R
    Int J Clin Oncol; 2002 Oct; 7(5):312-7. PubMed ID: 12402066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum soluble interleukin-2 receptor and immunohistochemical staining of IL-2R/Tac antigen in gastric cancer.
    Murakami S; Satomi A; Ishida K; Sakata H; Tsuji Y; Hibino S
    Oncol Rep; 1996 Jan; 3(1):69-73. PubMed ID: 21594317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the effect of serum interleukin-6 (IL-6) and soluble IL-6 receptor levels on survival of patients with colorectal cancer.
    Yeh KY; Li YY; Hsieh LL; Lu CH; Chou WC; Liaw CC; Tang RP; Liao SK
    Jpn J Clin Oncol; 2010 Jun; 40(6):580-7. PubMed ID: 20194250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
    Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A
    Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of soluble interleukin-2 receptor in patients with perennial allergic rhinitis before and after immunotherapy.
    Ohashi Y; Nakai Y; Sakamoto H; Ohno Y; Sugiura Y; Okamoto H; Tanaka A; Kakinoki Y; Kishimoto K; Hayashi M
    Ann Allergy Asthma Immunol; 1996 Sep; 77(3):203-8. PubMed ID: 8814045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of soluble CD30 and other markers in colorectal cancer patients.
    Iwagaki H; Hizuta A; Kohka H; Kobashi K; Nitta Y; Isozaki H; Takakura N; Tanaka N
    J Med; 1999; 30(1-2):111-21. PubMed ID: 10515247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer.
    Murakami S; Satomi A; Ishida K; Murai H; Matsuki M; Hashimoto T
    Cancer; 1994 Nov; 74(10):2745-8. PubMed ID: 7525035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
    Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
    Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum soluble interleukin-2 receptor as a predictor of lymph node metastasis in early gastric cancer.
    Murakami S; Sakata H; Tsuji Y; Okubo K; Hamada S; Hirayama R
    Dig Surg; 2002; 19(1):9-13; discussion 14. PubMed ID: 11961349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the levels of serum-soluble interleukin-2 receptor after surgical stress.
    Murakami S; Sakata H; Tsuji Y; Okubo K; Takahashi T; Kikuchi M; Hirayama R
    Surg Today; 2003; 33(8):565-70. PubMed ID: 12884092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between soluble interleukin 2 receptor levels and antidouble stranded DNA antibody levels in patients with systemic lupus erythematosus.
    Ward MM; Dooley MA; Christenson VD; Pisetsky DS
    J Rheumatol; 1991 Feb; 18(2):235-40. PubMed ID: 2023217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease.
    Tesch H; Günther A; Abts H; Jücker M; Klein S; Krueger GR; Diehl V
    Am J Pathol; 1993 Jun; 142(6):1714-20. PubMed ID: 8506943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Elevated soluble interleukin-2 receptor and interleukin-2 receptor positive cells in carcinomatous pleural effusions].
    Kojiro N; Moriwaki Y; Ito M; Nishiki M; Shirasaka T; Kokubu T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):100-4. PubMed ID: 2355670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of serum-soluble receptor for interleukin-2 in patients with colorectal cancer.
    Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N
    Surg Today; 1998; 28(10):1115-7. PubMed ID: 9786595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma.
    Chung YC; Chaen YL; Hsu CP
    Anticancer Res; 2006; 26(5B):3905-11. PubMed ID: 17094421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of the measurement of serum soluble IL-2 receptor alpha chain levels in clinical monitoring of non-Hodgkin lymphoma].
    Setoyama Y; Imai J; Ishikawa T; Sakaida H; Takaori-Kondo A; Kawamata S; Uchiyama T
    Rinsho Byori; 1994 Aug; 42(8):834-42. PubMed ID: 7933620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M; Darwish NA; Abdel-Aziz O
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.